Abstract
It is attractive to use vitamin B12 as a carrier for targeted delivery of cytotoxic agents such as platinum complexes owing to the high demand for vitamin B12 by fast proliferating cells. The basic {B12–CN–PtII} conjugates are recognized by intracellular enzymes and converted to coenzyme B12 in an enzymatic adenosylation assay. The reductive adenosylation of {B12–CN–PtII} conjugates leads to the release of the PtII complexes; thus, {B12–CN–PtII} conjugates can be considered as prodrugs. It is important not only to elucidate the activity of the cisplatin–B12 conjugates, but also to understand the mode of action on a molecular level. Chemical reduction of {B12–CN–PtII} conjugates with cobaltocene yielded cob(II)alamin and induced release of the corresponding PtII species. Kurnakov tests and coordination of 2′-deoxyguanosine or GMP to the released PtII complexes allowed isolation and characterization of PtII complexes as released during enzymatic adenosylation. The biological activity of these PtII complexes was evaluated. Since the cleaved PtII complexes show cytotoxicity, the {B12–CN–PtII} conjugates can be used for specific targeting of cancer cells and therapeutic drug delivery. Preliminary in vitro cytotoxicity studies indicated lower activity (IC50 between 8 and 88 μM) than found for pure cisplatin. Since active transport and receptor-mediated uptake limits the intracellular {B12–CN–PtII} concentration, comparison with pure cisplatin is of limited use. We could show that the PtII complexes cleaved from B12 exerted a cytotoxicity comparable to that of cisplatin itself. Cytotoxicity studies in vitamin B12 free media showed a dependence on the addition of transcobalamin II for B12–Pt(II) conjugates.
Similar content being viewed by others
References
Ojima I (2008) Acc Chem Res 41:2–3
Ferrari M (2005) Nat Rev Cancer 5:161–171
Panyam J, Labhasetwar V (2003) Adv Drug Deliv Rev 55:329–347
Moghimi SM, Hunter AC, Murray JC (2005) FASEB J 19:311–330
Ang WH, Dyson PJ (2006) Eur J Inorg Chem 4003–4018
Chourasia MK, Jain SK (2003) J Pharm Pharm Sci 6:33–66
Jansen FP, Vanderheyden JL (2007) Nucl Med Biol 34:733–735
Josephs D, Spicer J, O’Doherty M (2009) Target Oncol 4:151–168
Wiering B, Krabbe PFM, Jager GJ, Oyen WJG, Ruers TJM (2005) Cancer 104:2658–2670
Collins DA, Hogenkamp HPC (1997) J Nucl Med 38:717–723
Pathare PM, Wilbur DS, Heusser S, Quadros EV, McLoughlin P, Morgan AC (1996) Bioconjug Chem 7:217–232
Collins DA, Hogenkamp HPC, Gebhard MW (1999) Mayo Clin Proc 74:687–691
Wilbur DS, Hamlin DK, Pathare PM, Heusser S, Vessella RL, Buhler KR, Stray JE, Daniel J, Quadros EV, McLoughlin P, Morgan AC (1996) Bioconjug Chem 7:461–474
Collins DA, Hogenkamp HPC (2000) Mayo Foundation for Medical Education and Research, Regents of the University of Minnesota, USA, p WO0062808
Russell-Jones GJ, Arthur L, Walker H (1999) Int J Pharm 179:247–255
Russell-Jones G, McTavish K, McEwan J (2003) J Control Release 91:259–260
Russell-Jones G, McTavish K, McEwan J (2003) J Control Release 91:260–262
Collins DA, Hogenkamp HPC, O’Connor MK, Naylor S, Benson LM, Hardyman TJ, Thorson LM (2000) Mayo Clin Proc 75:568–580
Waibel R, Treichler H, Schaefer NG, van Staveren DR, Mundwiler S, Kunze S, Kuenzi M, Alberto R, Nuesch J, Knuth A, Moch H, Schibli R, Schubiger PA (2008) Cancer Res 68:2904–2911
Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK (2007) J Control Release 122:141–150
Chalasani KB, Russell-Jones GJ, Yandrapu SK, Diwan PV, Jain SK (2007) J Control Release 117:421–429
Fedosov SN, Grissom CB, Fedosova NU, Moestrup SK, Nexo E, Petersen TE (2006) FEBS J 273:4742–4753
Smeltzer CC, Cannon MJ, Pinson PR, Munger JDJ, West FG, Grissom CB (2001) Org Lett 3:799–801
Howard WA, Bayomi A, Natarajan E, Aziza MA, ElAhmady O, Grissom CB, West FG (1997) Bioconjug Chem 8:498–502
Bagnato JD, Eilers AL, Horton RA, Grissom CB (2004) J Org Chem 69:8987–8996
Jacobsen DW, Holland RJ, Montejano Y, Huennekens FM (1979) J Inorg Biochem 10:53–65
Kunze S, Zobi F, Kurz P, Spingler B, Alberto R (2004) Angew Chem Int Ed 43:5025–5029
Mundwiler S, Spingler B, Kurz P, Kunze S, Alberto R (2005) Chem Eur J 11:4089–4095
Ruiz-Sanchez P, Mundwiler S, Spingler B, Buan NR, Escalante-Semerena JC, Alberto R (2008) J Biol Inorg Chem 13:335–347
Pinedo HM, Schornagel JH (1996) Platinum and other metal coordination compounds in cancer chemotherapy, vol 2. Plenum Press, New York
McLean GR, Quadros EV, Rothenberg SP, Morgan AC, Schrader JW, Ziltener HJ (1997) Blood 89:235–242
Fonseca MV, Escalante-Semerena JC (2001) J Biol Chem 276:32101–32108
Fonseca MV, Buan NR, Horswill AR, Rayment I, Escalante-Semerena JC (2002) J Biol Chem 277:33127–33131
Davies MS, Cox JW, Berners-Price SJ, Barklage W, Qu Y, Farrell N (2000) Inorg Chem 39:1710–1715
Davies MS, Hall MD, Berners-Price SJ, Hambley TW (2008) Inorg Chem 47:7673–7680
Berners-Price SJ, Ronconi L, Sadler PJ (2006) Prog Nucl Mag Reson Spectrosc 49:65–98
Centerwall CR, Goodisman J, Kerwood DJ, Dabrowiak JC (2005) J Am Chem Soc 127:12768–12769
Sundquist WI, Ahmed KJ, Hollis LS, Lippard SJ (1987) Inorg Chem 26:1524–1528
Hartley FR (1973) The chemistry of platinum and palladium. Applied Science Publishers, London
Martins ET, Baruah H, Kramarczyk J, Saluta G, Day CS, Kucera GL, Bierbach U (2001) J Med Chem 44:4492–4496
Still BM, Kumar PGA, Aldrich-Wright JR, Price WS (2007) Chem Soc Rev 36:665–686
Flament JP, Tadjeddine M (1995) Chem Phys Lett 238:193–198
Gonnet F, Kocher F, Blais JC, Bolbach G, Tabet JC, Chottard JC (1996) J Mass Spectrom 31:802–809
Bancroft DP, Lepre CA, Lippard SJ (1990) J Am Chem Soc 112:6860–6871
Legendre F, Bas V, Kozelka J, Chottard JC (2000) Chem Eur J 6:2002–2010
Lovejoy KS, Todd RC, Zhang SZ, McCormick MS, D’Aquino JA, Reardon JT, Sancar A, Giacomini KM, Lippard SJ (2008) Proc Natl Acad Sci USA 105:8902–8907
Monti E, Gariboldi M, Maiocchi A, Marengo E, Cassino C, Gabano E, Osella D (2005) J Med Chem 48:857–866
Banerjee R (1999) Chemistry and biochemistry of B12. Wiley-Interscience, New York
Quadros EV, Nakayama Y, Sequeira JM (2009) Blood 113:186–192
Hollis LS, Sundquist WI, Burstyn JN, Heigerbernays WJ, Bellon SF, Ahmed KJ, Amundsen AR, Stern EW, Lippard SJ (1991) Cancer Res 51:1866–1875
Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467–2498
Acknowledgments
This project was supported financially by the Swiss National Science Foundation and the University of Zurich. We are grateful to Sergey Fedosov, Department of Molecular Biology at the University of Aarhus, Denmark, for a generous gift of TCII and helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ruiz-Sánchez, P., König, C., Ferrari, S. et al. Vitamin B12 as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies. J Biol Inorg Chem 16, 33–44 (2011). https://doi.org/10.1007/s00775-010-0697-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-010-0697-z